Aileen Feldman, MD
Psychiatry · Naples, FLNPI 1184647802
Payments from drug & device makers
Across 69 payments — averaging $47.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- AbbVie$408
- Lundbeck LLC$164
- Otsuka America Pharmaceutical, Inc.$148
- Amgen$116
- Boehringer Ingelheim$115
- plus $352 from 7 others
What the payments were for
- Speaking & faculty fees$1,80055%
- Travel & lodging$221%
- Food & beverage$1,40043%
- Education$301%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $1,948 |
| AbbVie(2 entities) | 29 | $408 |
| Lundbeck LLC | 8 | $164 |
| Otsuka America Pharmaceutical, Inc. | 8 | $148 |
| Amgen | 1 | $116 |
| Boehringer Ingelheim | 1 | $115 |
| Johnson & Johnson | 7 | $115 |
| Lilly USA, LLC | 1 | $97 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $50 |
| Almatica Pharma LLC | 2 | $36 |
| Sunovion Pharmaceuticals Inc. | 1 | $19 |
| Bausch Health US, LLC | 1 | $18 |
| Ironshore Pharmaceuticals Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRINTELLIX$1,800
- VRAYLAR$120
- AIMOVIG$116
- JARDIANCE$115
How this compares
$3,252 in reported general payments places this provider in the 75th percentile of 2,059 psychiatry providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 17 | $218 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 19 | $169 |
| Escitalopram Oxalate | 15 | $87 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Naples
- Edwin GomezWeston$24.9M
- Rishi KakarTamarac$23.9M
- Peter VentreOakland Park$18.7M
- Jose GamezHialeah$14.8M
- John JoyceJacksonville$13.6M
- Silvia Silva-DulucMiami$11.7M
- Kelley WilsonTampa$11.1M
- Emilio Mantero-AtienzaMiami Beach$10.9M
- Patricia JunqueraMiami$10.8M
- Olga LapeyraLauderhill$10M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.